SYMBOL:

    Up to 100 tickers separated by a space .....Watch Post-Market activities
Site Map FAQ Contact us Home Personalize
Company
Industry
Earnings
US Markets
Most Active
Portfolio
Tools
ETFs
Ratings
SHANGPHARMA
(NYSE:SHP Last Sale: 8.95 )
Fundamentals Charts Tech Analysis Industry Earnings
Company Profile   Details

Company Web Site
NYSE: (SHP : $8.95)
$167 million Market Cap at March 27, 2013
Biomedics SubIndustry up .00% / Health Industry up .00% Today
Research Report Earnings Snapshot - Last 11/20/16
Fact Sheet
Financial Statements
Peer Comparison
Annual Reports

Michael Xin Hui, Chmn./CEO, Kevin Penghui Chen, COO/CFO
China-based pharmaceutical and biotechnology research and development, or R&D, outsourcing company. Owns 100% of operating subsidiaries in China through two wholly-owned companies incorporated in Hong Kong, China Gateway Life Science (Holdings) Limited and ChemExplorer Company Limited. ADS=18 ordinary shares. IPO at $15 October 18, 2010. Raised $87 million, selling 5.8 million shares, 31% of the outstanding. Lead Manager: Citigroup.
Historical Charts    Technical Analysis
No Historical Data available for SHP

Type of Stock Symbol Last Sale Last Close Net +/- % +/- Low High Volume 52wk Low 52wk High Shares(M)
Common SHP $8.95 $ 0 $8.95 $8.97 125,228 $5.81 $8.99 18,644
Capitalization
Earnings Summary ()
*** No Earnings Available***
-10126
Common Stock $166,868

A
Google



QUICK NAVIGATION SITE SEARCH   Enter Keyword:
   
Home    Subscribe    Browser Help    Subscriber Services    B-to-B    Banks    Brokerage    Telco    Site Map    Legal    Contact/Email
Copyright © 1996 - 2025 Stock Smart with all rights reserved
Feed is currently being brought back up
Provided by Nanex